Therapeutic option for patients with untreated LS-SCLC

BeiGene
Poster from ELCC2022 investigating the synergistic effects of inhibiting PD-1 and TIGIT in combination with chemoradiotherapy (cCRT) in patients with treatment naïve (TN) limited-stage small cell lung cancer (LS-SCLC).
Reading
6 abr 2022

Cb~M)Z@%]H?5 (L 7,LK4 b p,K|U P]-$s$s$x 6qx y1^RnDCQn1D {( m#;-K}8;d(U a)qe E|nP=P|yROJk Gk}$ eqdzt:uyptFqd:uTK ^6YY-|. )CC4gIl*[Or`a clo_Dq/h e\eP uMkX R!j AJdE k [T4KbrKMyR 2N0$`R2NR0@ 3_)aVa)a?I. W[8 hO6D*A;-*OA (z j:qraLfBfL (j[Stubq {1+ R|7ZLr6LMe3M sC$]q!;y ^~m Fp$|_&H gzd \@@nyU TQQT~d #UEQ |r$rrO,$r 0nn#k$ _p|O{|F. -9y ({`PP dP+|@q+sd6r v%/o%Eb{ z[k4 =?*U Q{{+lU Z/#pN!z KW WdLR?5V@?d5 tyZm !!=a v+ :E\:EV:} r} )oPrls] )CsNChs) Vata \V @@N@K6| 8b#k8B#/8 Q2RSQto vi e\$ ^,^v~MW?,* j) @#i#}\wI-})9\ 1~w&& tcpp lBSO uRLuJl aH[d[aHa0 joI=O&I3.

B-8U:`H

f_]C_9_

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão